Search research articles
Contact Us
Filters
Showing results (51-60 of 224) with videos related to
Page
of 23
Sort By:
Clinical Medicine Insights. Oncology
|
July 26, 2023
Pleural Mesothelioma in the Era of Immunotherapy
Mathieu Chevallier, Floryane Kim, Alex Friedlaender, et al.
Current Treatment Options in Oncology
|
September 5, 2019
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC
Alex Friedlaender, Giuseppe Banna, Sandip Patel, et al.
Future Oncology (London, England)
|
October 23, 2024
Rates of febrile neutropenia and its causes in the real world
Maxime Borgeaud, Simona Perano, Alfredo Addeo, et al.
Cancer Journal (Sudbury, Mass.)
|
November 16, 2022
Antibody Drug Conjugates in Lung Cancer
Geoffrey Merle, Alex Friedlaender, Aakash Desai, et al.
JAMA Oncology
|
October 25, 2019
Tumor Mutation Burden-From Doubts to Concerns-In Reply
Alfredo Addeo, Giuseppe L Banna, Glen J Weiss
JAMA Oncology
|
May 31, 2019
Tumor Mutation Burden-From Hopes to Doubts
Alfredo Addeo, Giuseppe L Banna, Glen J Weiss
Ecancermedicalscience
|
January 26, 2019
Learning from the past to design better trials in second-line treatment for mesothelioma patients
Alfredo Addeo, Giuseppe Luigi Banna, Pierre-Yves Dietrich
Cancer Genomics & Proteomics
|
August 30, 2020
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
Mathieu Chevallier, Petros Tsantoulis, Alfredo Addeo, et al.
Cancer Genomics & Proteomics
|
October 30, 2019
The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience
Javier Torralvo, Alex Friedlaender, Verane Achard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 11, 2016
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?
Vittorio Fusco, Alberto Bedogni, Alfredo Addeo, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 224) with videos related to
Sort By:
Page
of 23
Clinical Medicine Insights. Oncology
|
July 26, 2023
Pleural Mesothelioma in the Era of Immunotherapy
Mathieu Chevallier, Floryane Kim, Alex Friedlaender, et al.
Current Treatment Options in Oncology
|
September 5, 2019
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC
Alex Friedlaender, Giuseppe Banna, Sandip Patel, et al.
Future Oncology (London, England)
|
October 23, 2024
Rates of febrile neutropenia and its causes in the real world
Maxime Borgeaud, Simona Perano, Alfredo Addeo, et al.
Cancer Journal (Sudbury, Mass.)
|
November 16, 2022
Antibody Drug Conjugates in Lung Cancer
Geoffrey Merle, Alex Friedlaender, Aakash Desai, et al.
JAMA Oncology
|
October 25, 2019
Tumor Mutation Burden-From Doubts to Concerns-In Reply
Alfredo Addeo, Giuseppe L Banna, Glen J Weiss
JAMA Oncology
|
May 31, 2019
Tumor Mutation Burden-From Hopes to Doubts
Alfredo Addeo, Giuseppe L Banna, Glen J Weiss
Ecancermedicalscience
|
January 26, 2019
Learning from the past to design better trials in second-line treatment for mesothelioma patients
Alfredo Addeo, Giuseppe Luigi Banna, Pierre-Yves Dietrich
Cancer Genomics & Proteomics
|
August 30, 2020
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
Mathieu Chevallier, Petros Tsantoulis, Alfredo Addeo, et al.
Cancer Genomics & Proteomics
|
October 30, 2019
The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience
Javier Torralvo, Alex Friedlaender, Verane Achard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 11, 2016
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?
Vittorio Fusco, Alberto Bedogni, Alfredo Addeo, et al.
Page
of 23